Demonstration of commitment by K562 human erythroleukemia cells.
Commitment, i.e. the decision to express a differentiated phenotype and to terminate proliferation irreversibly in the absence of inducer, was investigated in K562 human erythroleukemia cells. Cells were cultured for 0, 1, 2, 3, or 4 days with inducer and then plated in medium containing methylcellulose without inducer. Daily following plating, hemoglobin content was scored by benzidine staining and growth was assessed by estimating cell number per colony. With all inducers used, three types of colonies were found, those containing only benzidine positive cells, those containing only benzidine negative cells, and those containing both benzidine positive and benzidine negative cells (mixed colonies). Thymidine produced a progressive increase in the percentage of positive and mixed colonies and a progressive fall in the percentage of negative colonies. Whereas negative colonies grew at an exponential rate with a generation time of about 20 hours, positive colonies reached an average maximum size of 16 cells, representing a total of four divisions. Butyrate had a similar effect except that the rise was greater for mixed colonies than for positive colonies and the plateau in positive colony size was less evident. In contrast, CO2 depletion or hemin treatment induced an increase in the fraction of cells staining benzidine positive which was lost rapidly upon removal of the inducing condition. Thus, of the four conditions, thymidine and butyrate caused commitment whereas hemin and CO2 depletion did not. Thus K562 cells, like Friend cells, demonstrate commitment, but, unlike Friend cells, demonstrate a significant rate of commitment in the absence of inducer and hence form a significant percentage of mixed colonies with or without inducer.
D001560:Benzidines / Q000378:metabolism; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D002448:Cell Adhesion; D002454:Cell Differentiation; D002455:Cell Division; D002460:Cell Line; D005622:Friend murine leukemia virus; D006427:Hemin / Q000494:pharmacology; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology*; D007942:Leukemia, Experimental / Q000473:pathology; D010641:Phenotype; D013936:Thymidine / Q000378:metabolism
D001560:Benzidines; D002087:Butyrates; D020148:Butyric Acid; C029876:benzidine; D006427:Hemin; D013936:Thymidine